Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?
Publication
, Journal Article
Basch, E; Somerfield, MR; Partridge, A; Schnipper, L; Lyman, GH
Published in: J Oncol Pract
November 2011
Duke Scholars
Published In
J Oncol Pract
DOI
EISSN
1935-469X
Publication Date
November 2011
Volume
7
Issue
6
Start / End Page
398 / 401
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Basch, E., Somerfield, M. R., Partridge, A., Schnipper, L., & Lyman, G. H. (2011). Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract, 7(6), 398–401. https://doi.org/10.1200/JOP.2011.000414
Basch, Ethan, Mark R. Somerfield, Ann Partridge, Lowell Schnipper, and Gary H. Lyman. “Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?” J Oncol Pract 7, no. 6 (November 2011): 398–401. https://doi.org/10.1200/JOP.2011.000414.
Basch E, Somerfield MR, Partridge A, Schnipper L, Lyman GH. Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011 Nov;7(6):398–401.
Basch, Ethan, et al. “Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?” J Oncol Pract, vol. 7, no. 6, Nov. 2011, pp. 398–401. Pubmed, doi:10.1200/JOP.2011.000414.
Basch E, Somerfield MR, Partridge A, Schnipper L, Lyman GH. Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011 Nov;7(6):398–401.
Published In
J Oncol Pract
DOI
EISSN
1935-469X
Publication Date
November 2011
Volume
7
Issue
6
Start / End Page
398 / 401
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis